Company profile
Dogwood Therapeutics, Inc. insider acquisitions
Company CIK 0001818844 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
6 dated transactions · 7 of 7 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Dec 4, 2025 | Dogwood Therapeutics, Inc.Stock Option (right to buy) | Duncan Gregory Scott | Stock award |
| Dec 4, 2025 | Dogwood Therapeutics, Inc.Stock Option (right to buy) | Gendreau Roger Michael | Stock award |
| Dec 4, 2025 | Dogwood Therapeutics, Inc.Stock Option (right to buy) | Grosswald Ralph | Stock award |
| Dec 4, 2025 | Dogwood Therapeutics, Inc.Stock Option (right to buy) | Walsh Angela | Stock award |
| Nov 21, 2025 | Dogwood Therapeutics, Inc.Common Stock | CK Life Sciences Intl (Holdings) Inc · Sealbond Ltd · Conjoint Inc. | Conversion |
| Nov 21, 2025 | Dogwood Therapeutics, Inc.Common Stock | CK Life Sciences Intl (Holdings) Inc · Sealbond Ltd · Conjoint Inc. | Conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
DWTX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Duncan Gregory ScottCHIEF EXECUTIVE OFFICER · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 460,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Gendreau Roger MichaelCHIEF MEDICAL OFFICER | Stock awardStock Option (right to buy)Derivative security · Code A | 150,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Grosswald RalphSVP OF OPERATIONS | Stock awardStock Option (right to buy)Derivative security · Code A | 150,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Walsh AngelaChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 150,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | CK Life Sciences Intl (Holdings) IncDirector · 10% owner · See Remarks Sealbond LtdDirector · 10% owner · See Remarks Conjoint Inc.Director · 10% owner · See Remarks Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 2,842,638 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | CK Life Sciences Intl (Holdings) IncDirector · 10% owner · See Remarks Sealbond LtdDirector · 10% owner · See Remarks Conjoint Inc.Director · 10% owner · See Remarks Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 21,610,950 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
6 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →